63 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
Officer. Pelthos is focused on the commercialization of innovative, safe, and efficacious therapeutic products for patients suffering from conditions … the acquisition of royalties or by developing innovative therapeutics; products under development by Ligand or its partners may not receive regulatory approval
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
or by developing innovative therapeutics; products under development by Ligand or its partners may not receive regulatory approval; the total addressable market
8-K
EX-99.1
o85k2xmj jd8ezvg76
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
425
EX-99.1
feoupidj7o
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
7qwq twey2
21 Jun 22
Regulation FD Disclosure
6:19am
425
EX-99.3
xrjvdv1q
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.3
w4nytwdw
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
3pbazte7 wgg
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
EX-99.1
8s7d9
3 Feb 21
Ligand Reports Fourth Quarter and Full Year 2020 Financial Results
7:45am
8-K
EX-99.1
ryelvjscr 0l
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K
EX-99.1
0tfwm98s88ii7 61
6 May 20
Ligand Reports First Quarter 2020 Financial Results
4:03pm
8-K
EX-99.1
hjduu9 lpmqp63
2 Apr 20
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
4:18pm
8-K
EX-99.1
6xykkdvs jhl
6 Feb 20
Ligand Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm
8-K
EX-99.1
lqone6fg8k5 8k
5 Nov 19
Ligand Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-99.1
p0k6e
30 Jul 19
Ligand Reports Second Quarter 2019 Financial Results
8:13am